Waverton Investment Management Ltd maintained its stake in shares of Monsanto Co. (NYSE:MON) during the second quarter, Holdings Channel reports. The fund owned 23,800 shares of the company’s stock at the end of the second quarter. Waverton Investment Management Ltd’s holdings in Monsanto were worth $2,461,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. State Street Corp boosted its stake in shares of Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares during the period. Geode Capital Management LLC raised its position in shares of Monsanto by 5.2% in the first quarter. Geode Capital Management LLC now owns 3,718,453 shares of the company’s stock worth $325,622,000 after buying an additional 182,728 shares in the last quarter. Legal & General Group Plc raised its position in shares of Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock worth $170,663,000 after buying an additional 46,878 shares in the last quarter. Carmignac Gestion acquired a new position in shares of Monsanto during the second quarter worth $197,555,000. Finally, UBS Asset Management Americas Inc. raised its position in shares of Monsanto by 0.5% in the first quarter. UBS Asset Management Americas Inc. now owns 1,731,414 shares of the company’s stock worth $151,914,000 after buying an additional 8,453 shares in the last quarter. Hedge funds and other institutional investors own 79.02% of the company’s stock.
Shares of Monsanto Co. (NYSE:MON) traded down 0.14% during trading on Friday, reaching $103.36. 2,391,593 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $104.88 and a 200-day moving average price of $101.34. The company has a market capitalization of $45.23 billion, a PE ratio of 45.49 and a beta of 1.19. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.19) EPS. On average, equities analysts forecast that Monsanto Co. will post $4.89 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is 71.05%.
A number of research analysts have weighed in on MON shares. Piper Jaffray Cos. reissued an “overweight” rating and set a $127.00 price target (up previously from $95.00) on shares of Monsanto in a research note on Monday, June 13th. Argus reissued a “buy” rating and set a $128.00 price target (up previously from $111.00) on shares of Monsanto in a research note on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the stock a “sell” rating in a research note on Monday, June 27th. Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price target on the stock in a research note on Monday, June 27th. Finally, Jefferies Group reissued a “buy” rating on shares of Monsanto in a research note on Wednesday, June 29th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $114.67.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.